Journal:
:international journal of hematology-oncology and stem cell research
0
mozaffar aznab hematology-oncology department, kermanshah university of medical science (kums), tehran, iran
a tabarroki hematology-oncology department, kermanshah university of medical science (kums), tehran, iran
gh mohsseni hematology-oncology department, kermanshah university of medical science (kums), tehran, iran
f farshian faculty of medical sciences, kermanshah university of medical science (kums), tehran, iran
k kavyani statistic department, kermanshah university of medical science (kums) tehran, iran
introduction: colo-rectal cancer has 10% prevalence, among all of the cancer proportionally and also it is the third common cancer in the both sexes. two recently introduced active drugs in the treatment of advanced colorectal cancer (acc) are irinotecan and oxaliplatin. the combinations of oxaliplatin (oxa) or irinotecan (iri) with 5fu-lv have been accepted as standard treatment for metastatic...
